Adrian Gottschalk

Adrian Gottschalk

Company: Foghorn Therapeutics

Job title: Chief Executive Officer

Seminars:

CEO Think Tank: A Strategic Look at Targeted Protein Degradation & Induced Proximity Field 9:30 am

Moderator: Neil Torbett, Chief Executive Officer, Phoremost Assessing what we are learning from clinical candidates Considering pipeline prioritization for mid to large biotechs progressing multiple programs Advice to fledging biotechs on advancing through discovery and enabling clinical successRead more

day: Day One AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.